Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

August 23, 2019

Study Completion Date

August 23, 2019

Conditions
Type 2 Diabetes MellitusHeart Failure
Interventions
DRUG

Saxagliptin

5 mg or 2.5 mg, plain, yellow, biconvex, round, film-coated tablet

DRUG

Sitagliptin

50 mg or 100 mg, gray capsule

DRUG

Placebo to match saxagliptin

2.5 mg or 5 mg, plain, yellow, biconvex, round, film-coated tablet

DRUG

Placebo to match sitagliptin

50 mg or 100 mg, gray capsule

Trial Locations (74)

1122

Research Site, Budapest

1134

Research Site, Budapest

1142

Research Site, Sofia

1171

Research Site, Budapest

1431

Research Site, Sofia

1606

Research Site, Sofia

1618

Research Site, Sofia

1784

Research Site, Sofia

4032

Research Site, Debrecen

4200

Research Site, Hajdúszoboszló

4400

Research Site, Nyíregyháza

4600

Research Site, Kisvárda

5900

Research Site, Orosháza

6000

Research Site, Kecskemét

7623

Research Site, Pécs

8000

Research Site, Székesfehérvár

8230

Research Site, Balatonfüred

10330

Research Site, Bangkok

10400

Research Site, Bangkok

10455

Research Site, The Bronx

10459

Research Site, The Bronx

10700

Research Site, Bangkoknoi

13620

Research Site, Seongnam-si

18450

Research Site, Hwaseong-si

18840

Research Site, Sayre

26426

Research Site, Wŏnju

29302

Research Site, Spartanburg

32174

Research Site, Ormond Beach

33007

Research Site, Rivne

33133

Research Site, Miami

35015

Research Site, Daejeon

40002

Research Site, Khon Kaen

49241

Research Site, Busan

50200

Research Site, Chiang Mai

60610

Research Site, Chicago

61469

Research Site, Gwangju

64111

Research Site, Milwaukee

76005

Research Site, Ivano-Frankivsk

76018

Research Site, Ivano-Frankivsk

77089

Research Site, Houston

79015

Research Site, Lviv

90502

Research Site, Torrance

91786

Research Site, Upland

109263

Research Site, Moscow

115516

Research Site, Moscow

121551

Research Site, Moscow

150062

Research Site, Yaroslavl

194354

Research Site, Saint Petersburg

197341

Research Site, Saint Petersburg

199226

Research Site, Saint Petersburg

426035

Research Site, Izhevsk

500365

Research Site, Brasov

603018

Research Site, Nizhny Novgorod

630055

Research Site, Novosibirsk

630087

Research Site, Novosibirsk

630089

Research Site, Novosibirsk

634012

Research Site, Tomsk

634050

Research Site, Tomsk

650002

Research Site, Kemerovo

700304

Research Site, Iași

700515

Research Site, Iași

2520997

Research Site, Viña del Mar

4270918

Research Site, Talcahuano

8207257

Research Site, Santiago

8360160

Research Site, Santiago

8380453

Research Site, Santiago

8910259

Research Site, Santiago

G7H 7K9

Research Site, Chicoutimi

02841

Research Site, Seoul

03080

Research Site, Seoul

03722

Research Site, Seoul

02091

Research Site, Kyiv

02660

Research Site, Kyiv

03680

Research Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY